1/20/2020 2:05:46 AM
AstraZeneca: Lynparza Regulatory Submission Granted Priority Review In US
1/20/2020 2:04:39 AM
AstraZeneca: Imfinzi And Tremelimumab Granted Orphan Drug Designation In US
1/13/2020 2:05:56 AM
AstraZeneca Provides Update On Phase III STRENGTH Trial For Epanova In Mixed Dyslipidaemia
1/13/2020 2:05:21 AM
AstraZeneca Says SNDA For Lynparza In Combination With Bevacizumab Accepted And Granted Priority Review In The US
1/6/2020 2:09:23 AM
AstraZeneca: FDA Accept SNDA And Granted Priority Review For Farxiga
1/6/2020 2:08:22 AM
AstraZeneca Says Lokelma Approved In China For Adult Patients With Hyperkalaemia
12/30/2019 2:02:49 AM
AstraZeneca: FDA Approves Lynparza For Pancreatic Cancer In The US
12/23/2019 8:44:07 AM
Fortress Biotech Enters Worldwide License Deal With AstraZeneca And Cincinnati Children’s Hospital Medical Center
12/23/2019 2:03:44 AM
AstraZeneca Says Budesonide/glycopyrronium/formoterol Fumarate Approved In China
12/23/2019 2:02:37 AM
AstraZeneca And Daiichi Sankyo Announce FDA Approves Enhertu In The US
12/20/2019 2:02:31 AM
AstraZeneca Divests Rights To Arimidex And Casodex In Europe
12/16/2019 2:03:20 AM
AstraZeneca Completes Deal With Cheplapharm For Rights To Seroquel
and Seroquel XR In Europe And Russia